I picked up some of the GRCYW warrants last week around the 4-6 cent range. Definitely an extremely high level of risk here. Next immediate hurdle is getting the October 2022 extension approved, but if they accomplish that I think the risk/reward becomes quite a bit more interesting.
What kind of captured my eye is a statement made in the March 11 PRE 14A filing. As far as I am aware (if my filing text searches are accurate), this is the first time that the GRCY SPAC has ever mentioned they are currently having discussions with merger candidates. Seems somewhat encouraging to me, since this type of language has never appeared in any previous filing by GRCY.
Plus, depending on how serious China is on smoothing over regulatory tensions with the United States perhaps we are entering a new window of opportunity for better US-listed China/Asia-related stock performance. This could dramatically improve some SPAC, shell and reverse merger investments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.